GlassScriptPhysician profile
Roodolph Joseph
NPI 1114499779
$1,096.75
in general payments reported to CMS, 2019-2025
12 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,096.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $188.21 | 2025 | Dupixent |
| Glaxosmithkline, LLC. | $165.04 | 2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $159.96 | 2025 | Tezspire, Fasenra |
| Takeda Pharmaceuticals U.S.A., INC. | $148.22 | 2025 | Takhzyro, Hyqvia |
| Csl Behring | $128.51 | 2025 | Hizentra |
| Genzyme Corporation | $112.45 | 2025 | |
| Novartis Pharmaceuticals Corporation | $72.70 | 2025 | |
| Baxter Healthcare | $27.31 | 2025 | |
| Paratek Pharmaceuticals, INC. | $27.21 | 2025 | Xhance |
| Organon LLC | $25.21 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $24.61 | 2025 | Neffy |
| Biocryst US Sales Co., LLC | $17.32 | 2025 | Orladeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roodolph Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.